HOW WELL DOES ULTRASOUND-ASSESSED SYNOVITIS IN REDUCED JOINT SETS PREDICT THE RESPONSE TO SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL DMARDS? - EXPLORATORY RESULTS FROM A PHASE 3B STUDY

被引：0

作者：

D'agostino, M. A. ^{[1
]}

Conaghan, P. G. ^{[2
]}

Gaillez, C. ^{[3
]}

Naredo, E. ^{[4
]}

Mandl, P. ^{[5
]}

Carron, P. ^{[6
]}

Senolt, L. ^{[7
,8
]}

Rosa, J. ^{[9
]}

Lopez-Rodriguez, A. ^{[10
]}

Goyanka, P. ^{[11
]}

Sahoo, B. G. ^{[12
]}

Bao, W. ^{[13
]}

Schett, G. ^{[14
]}

Boers, M. ^{[15
]}

机构：

[1] Univ Cattolica Sacro Cuore, Rheumatol, Rome, Italy

[2] Univ Leeds, Rheumatol, London, England

[3] Novartis Pharma AG, Immunol & Rheumatol, Basel, Switzerland

[4] Hosp Fdn Jimenez Diaz & Autonoma Univ, Dept Rheumatol & Joint & Bone Res Unit, Madrid, Spain

[5] Med Univ Vienna, Div Rheumatol, Vienna, Austria

[6] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium

[7] Charles Univ Prague, Inst Rheumatol, Prague, Czech Republic

[8] Charles Univ Prague, Dept Rheumatol, Prague, Czech Republic

[9] Hosp Italiano Buenos Aires & Univ Inst, Rheumatol Unit, Internal Med Serv, Buenos Aires, DF, Argentina

[10] PSOAPS Psoriasis Clin & Res Ctr, Dermatol Country, Guadalajara, Mexico

[11] Novartis Healthcare Pvt Ltd, Clin Project Management, Hyderabad, India

[12] Novartis Healthcare Pvt Ltd, Biostat, Hyderabad, India

[13] Novartis Pharmaceut, Biostat, East Hanover, NH USA

[14] FAU Erlangen Nurnberg & Univ Klinikum Erlangen, Dept Internal Med 3, Erlangen, Germany

[15] Vrije Univ, Amsterdam UMC, Dept Epidemiol & Data Sci, Amsterdam, Netherlands

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Psoriatic arthritis; bDMARD;

D O I：

10.1136/annrheumdis-2023-eular.2548

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0225

引用

页码：340 / 341

页数：2

共 50 条

[31] SECUKINUMAB IMPROVES MINIMAL DISEASE ACTIVITY RESPONSE RATES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: DATA FROM THE RANDOMIZED PHASE 3 STUDY, FUTURE 2
Coates, L. C.
Mease, P.
Kirkham, B.
McLeod, L. D.
Mpofu, S.
Karyekar, C.
Gandhi, K.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 605 - 605
[32] EFFICACY AND SAFETY OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AFTER INADEQUATE RESPONSE OR INTOLERANCE TO DMARDs: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND KEEPsAKE 1 TRIAL
Kristensen, L. E.
Keiserman, M.
Papp, K.
Mccasland, L.
White, D.
Barcomb, L.
Lu, W.
Wang, Z.
Soliman, A. M.
Eldred, A.
Behrens, F.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1315 - 1316
[33] SAFETY AND EFFICACY OF FILGOTINIB IN PATIENTS AGED 65 YEARS AND OLDER: RESULTS FROM A PHASE 3 STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS (BDMARD-IR)
Kalunian, Kenneth
Gottenberg, Jacques-Eric
Genovese, Mark C.
Mozaffarian, Neelufar
Bartok, Beatrix
Matzkies, Franziska
Gao, Jie
Guo, Ying
Takeuchi, Tsutomu
de Vlam, Kurt
Walker, David
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 748 - 749
[34] SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGICS: 3-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY
Mease, P. J.
Setty, A.
Papp, K.
Van den Bosch, F.
Tsuji, S.
Keiserman, M.
Carter, K.
Mccaskill, R.
Mcdearmon-Blondell, E.
Wung, P.
Tillett, W.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1136 - 1137
[35] Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Liu, Jinjing
Jiang, Ying
Zhang, Shangzhu
Liu, Shengyun
Su, Jingbo
Lin, Changsong
He, Xiaohong
Wu, Rui
Yang, Lei
Liu, Huaxiang
Duan, Xinwang
Xu, Shengqian
Luo, Hui
Liu, Jing
Xie, Qibing
Mi, Cundong
Chen, Lin
Zhang, Ning
Gong, Huiping
Zhu, Jing
Li, Yasong
Wei, Hua
Qian, Long
Wang, Jian
Shi, Xiaofei
Jin, Hongtao
Jiang, Zhenyu
Xie, Xi
Zhan, Feng
Geng, Xiuqin
Zheng, Zhaohui
Du, Zhengfu
Dong, Guangchao
Sun, Yuqi
Zeng, Xiaofeng
ANNALS OF THE RHEUMATIC DISEASES, 2025, 84 (02) : 188 - 200
[36] Efficacy and Safety of LNK01001 in Chinese Patients with Moderate to Severe Active Rheumatoid Arthritis with an Inadequate Response to Conventional Synthetic DMARDs: 24-week Results from a Phase 2 Trial
Wu, Chanyuan
Wang, Xuebin
Hu, Jiankang
Shi, Xiaofei
Wang, Xiaoxia
Zhang, Xuan
Liu, Ju
Rao, Hui
Zhao, Jianhong
Du, Rong
Jiang, Zhenyu
Liu, Huaxiang
Liu, Lin
Liu, Shengyun
Xie, Changhao
Liao, Xiangping
Dai, Lie
Hou, Zhiduo
Jin, Jingchun
Li, Tianwang
Meng, Deqian
Wang, Yongfu
Wu, Jian
Gu, Jieruo
Wei, Wei
Zhuang, Yu
Wang, Kuanting
Zhang, Rong
Zhang, Xiao
Wei, Huaping
Wan, Zhao-Kui
Wang, Jun
Vazquez, Michael
Wu, Henry
Zeng, Xiaofeng
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5210 - 5212
[37] A 3-arm, Randomized, Open-label, Parallel Active Controlled, Multicentre International Study to Compare the Response of Ultrasound-assessed Synovitis to Baricitinib, Alone and Combined with Methotrexate versus Etanercept in Rheumatoid Arthritis Patients
Naredo, Esperanza
Olivas-Vergara, Otto
Borges, Pablo E.
Recuero-Diaz, Sheila
Saraiva, Fernando
Martinho, Joana
Costa, Filipa
Tenazinha, Catarina
Monteiro, Margarida
Melo, Ana Teresa
Rodriguez-Garcia, Ana
Guillen-Astete, Carlos A.
Blanco-Caceres, Boris A.
Boteanu, Alina L.
Mera-Varela, Antonio
Pampin, Eva Perez
Golan, Yolanda Lopez
Fernandez, Cristina Campos
Gil, Jorge Juan Fragio
Mazario, Roxana Gonzalez
De Agustin, Juan Jose
Sturchio, Gustavo Anez
Tarancon, Luis Coronel
Vicente-rabaneda, Esther
Castaneda, Santos
Llorente-Cubas, Irene
Stoenoiu, Maria S.
Adrien, Nzeusseu Toukap
Padovano, Ilaria
Gouze, Helene
Leboime, Ariane
Breban, Maxime
Uson, Jaqueline
Villaverde, Virginia
Steiner, Martina
Dangond, Cristina Vergara
Romero, Maria Beatriz Paredes
Fernandez, Santiago Munoz
Perez-Garcia, Carolina
Meraz-Ostiz, Juan Antonio
Finzel, Stephanie
Kanne, Anna-Maria
Mediero, Aranzazu
Herencia, Carmen
Herrero-Beaumont, Gabriel
Largo, Raquel
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3981 - 3983
[38] PRESENCE OF POOR PROGNOSTIC FACTORS MAY PREDICT RESPONSE TO ABATACEPT IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A POST HOC ANALYSIS FROM A PHASE III STUDY
Mease, P.
McInnes, I.
Strand, V.
FitzGerald, O.
Ahmad, H.
Johnsen, A.
Ye, J.
Banerjee, S.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 951 - 951
[39] Presence of Poor Prognostic Factors May Predict Response to Abatacept in Patients with Active Psoriatic Arthritis: Results from a Post Hoc Analysis from a Phase III Study
Mease, Philip J.
McInnes, Iain B.
Strand, Vibeke
FitzGerald, O.
Ahmad, H.
Johnsen, A.
Ye, J.
Banerjee, S.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[40] SECUKINUMAB SIGNIFICANTLY DECREASED JOINT SYNOVITIS MEASURED BY POWER DOPPLER ULTRASONOGRAPHY IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: PRIMARY (12WEEK) RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED PHASE 3 STUDY
D'Agostino, Maria-Antonietta
Schett, Georg
Lopez Rodriguez, Alejandra
Senolt, Ladislav
Maldonado-Cocco, Jose
Burgos-Vargas, Ruben
Naredo, Esperanza
Carron, Philippe
Boers, Maarten
Duggan, Anne-Marie
Goyanka, Punit
Gaillez, Corine
RHEUMATOLOGY, 2021, 60 : 100 - +

← 1 2 3 4 5 →